11/2/2016
By Charles Payne, CEO & Principal Analyst

Yesterday was the first time the market blinked at the prospect of a Trump presidency as the polls tightened, and some showed the Republican nominee taking the lead?  However, it was another politician that pulled the rug from stocks driving the major indices to their worst levels of the session.  Bernie Sanders took aim at the drug industry, Eli Lilly in particular, for the 700% spike in Humalog insulin over the past two decades. 

It has to be abundantly clear that many businesses are going to have to adjust business practices no matter who wins next Tuesday.  On that note, I think it’s important that your portfolio reflects this new reality. There are stocks that I think will win big no matter who is in the White House, including military/defense contractors.

Charles Payne
Wall Street Strategies

Add a Comment!